+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Consumer Healthcare Market - Global Forecast to 2030- Product Image
Consumer Healthcare Market - Global Forecast to 2030- Product Image
Sale

Consumer Healthcare Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336904
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Consumer Healthcare Market grew from USD 356.94 billion in 2024 to USD 383.68 billion in 2025. It is expected to continue growing at a CAGR of 7.43%, reaching USD 548.72 billion by 2030.

The consumer healthcare sector stands at a pivotal juncture as shifting demographics, regulatory reforms, and technology-driven innovations converge to redefine patient experiences and industry priorities. Rising health consciousness among consumers, amplified by the pandemic’s long-term effects, has spurred demand for accessible self-care solutions spanning preventive, curative, and wellness categories. Simultaneously, tightening regulations around safety and efficacy are driving manufacturers to prioritize transparency and robust quality management systems. Digital health platforms and e-commerce channels are unlocking new avenues for engagement, enabling personalized recommendations and seamless supply chain operations. In this dynamic environment, industry leaders must navigate interlinked factors-from ingredient sourcing to patient adherence-while capitalizing on emerging opportunities in telehealth, data analytics, and sustainable packaging. This introduction frames the broader market landscape and sets the stage for examining transformative shifts, policy impacts, segmentation nuances, regional dynamics, leading players, and strategic imperatives that will shape the future of consumer healthcare.

Transformative Shifts in the Consumer Healthcare Landscape

Over the past five years, the consumer healthcare market has undergone profound transformations driven by digital disruption, shifting patient expectations, and innovation in product development. Rapid adoption of telemedicine and remote patient monitoring has blurred traditional boundaries between prescription and over-the-counter care, enabling clinicians to prescribe self-care regimens via connected platforms. Consumers increasingly expect data-driven insights, whether through wearable devices that track health metrics or mobile apps that deliver customized wellness plans. Moreover, sustainability has emerged as a non-negotiable priority, prompting companies to use eco-friendly packaging and source active compounds from renewable resources. Healthcare providers and retailers are forging strategic alliances to integrate supply chains, ensuring consistent product availability and enhancing pharmacovigilance. As these shifts gain momentum, agility in regulatory compliance, technology integration, and consumer engagement will distinguish market leaders from followers.

Cumulative Impact of United States Tariffs 2025

In 2025, new United States tariffs targeting active pharmaceutical ingredients and certain over-the-counter supplies are set to reshape cost structures and global sourcing strategies. Manufacturers that historically relied on low-cost imports from traditionally exempt regions now confront increased duties, compelling them to reevaluate contract terms and supplier portfolios. This realignment carries downstream implications: wholesale distributors are adjusting pricing models to maintain margins, while retailers face pressure to absorb or pass on incremental costs. Concurrently, companies are accelerating localization efforts, investing in domestic manufacturing capacity and establishing regional production hubs to mitigate tariff exposure. While initial cost inflation may compress profitability, the shift toward regional self-reliance enhances supply chain resilience and reduces lead times. Over the long term, the tariff-driven impetus for nearshoring is expected to catalyze innovation in process chemistry and drive partnerships with advanced manufacturing firms.

Key Segmentation Insights

Market segmentation reveals multifaceted opportunities across product attributes and consumer demographics. When examining product type, the ecosystem spans nonprescription remedies alongside physician-prescribed therapies, each facing distinct regulatory and reimbursement challenges. Delving into formulation, liquid dosage variants include suspensions and syrups, semi-solid options encompass gels and ointments, and solid forms range from capsules to powders and tablets, requiring tailored manufacturing capabilities. Application-wise, focus areas such as dermatology, diabetes management, gastrointestinal health, and pain alleviation attract specialized R&D investments and targeted marketing campaigns. Distribution channels extend through direct sales, digital storefronts, and brick-and-mortar outlets, where retail pharmacies and supermarket chains compete for shelf space. From an end-user perspective, segments cover the general adult population, specific geriatric groups, pediatric cohorts, and young adults, each presenting unique requirements for dosage, flavor, and packaging. Ingredient-driven segmentation spans both active and inactive components, the former highlighting natural bioactives and the latter emphasizing binders and preservatives integral to product stability. Disease indication analysis prioritizes cardiovascular care, neurological support, and respiratory wellness, while packaging variations include blister packs, bottles, and tubes designed for convenience and compliance. Consumer behavior further differentiates the market into brand-oriented shoppers, value-driven buyers, and eco-conscious advocates. Finally, therapeutic focus ranges from autoimmune conditions to infectious disease remedies and cancer support, with oncology solutions subdivided into chemotherapy and immunotherapy agents, while treatment approaches alternate between curative and symptomatic relief.

Key Regional Insights

Geographic trends underscore diverse growth trajectories and regulatory environments. In the Americas, robust healthcare infrastructure, widespread insurance coverage, and mature retail networks drive demand for innovative formulations and digital health solutions. Conversely, Europe, the Middle East & Africa exhibit heterogeneous market conditions: Western European nations emphasize stringent safety standards and sustainability mandates, while emerging economies in Eastern Europe, the Gulf region, and North Africa present untapped potential for generic and value-chain partnerships. In the Asia-Pacific region, rapid urbanization and rising disposable incomes fuel expansion of consumer self-care, with countries such as China, India, and Australia leading digital pharmacy adoption and telehealth integration. Local regulatory frameworks vary widely, necessitating tailored approval strategies and compliance roadmaps. Cross-border e-commerce and multinational trade agreements further influence market access, prompting companies to establish regional hubs and leverage free trade zones to streamline distribution and optimize tariff benefits.

Key Companies Insights

Major industry participants span global conglomerates, regional specialists, and emerging biotech firms. Abbott Laboratories Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Limited, AMCO Proteins, American Health Inc., Amway Corporation by Alticor corporation, Axtria Inc., BASF SE, Bayer AG, Bionova Lifesciences by Pragati Biocare Pvt. Ltd., Boehringer Ingelheim International GmbH, Cipla, Inc., Dr. Reddy's Laboratories, Eli Lilly and Company, Endo Pharmaceuticals PLC by DuPont de Nemours, Inc., Gemini Pharmaceuticals Inc., Glanbia PLC, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Henin Lukinz Pvt. Ltd., Herbalife Ltd., Hetero Drugs Ltd., Himalaya Wellness Company, Iovate Health Sciences International Inc., Ipsen S.A., Johnson & Johnson Services, Inc., Koninklijke DSM N.V., Lonza Group Ltd., Lupin Limited, Mankind Pharma, MusclePharm Corporation, Mylan Pharmaceuticals Pvt. Ltd. by Viatris, Nature's Bounty, Inc. by Nestlé S.A., Novartis AG, Omega Protein Corporation, Pfizer Inc., Piramal Group, Procter & Gamble Company, PureTek Corporation, QuestNutrition, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ventus Pharmaceuticals Private Limited, and Zoic Biotech Private Limited are at the forefront of product innovation, strategic partnerships, and digital transformation. These players are investing heavily in R&D, forging alliances with technology firms to develop AI-driven drug discovery and personalized nutrition platforms, and adopting sustainable sourcing practices to meet evolving consumer and regulatory demands.

Actionable Recommendations for Industry Leaders

To thrive in this evolving environment, industry leaders should adopt a multi-pronged approach. First, prioritize diversification of supply chains by establishing flexible regional manufacturing sites and engaging multiple qualified suppliers to buffer against tariff volatility and geopolitical disruptions. Second, accelerate digital transformation through investment in predictive analytics for demand forecasting, blockchain-enabled traceability for ingredient provenance, and omnichannel engagement platforms that integrate telehealth, e-commerce, and remote patient monitoring. Third, embed sustainability into product life cycles by sourcing renewable raw materials, minimizing single-use plastics, and pursuing circular packaging models. Fourth, tailor product portfolios to consumer segments identified through advanced psychographic and demographic analytics, ensuring formulations, flavor profiles, and packaging designs resonate with distinct age groups, health conditions, and environmental preferences. Finally, build collaborative partnerships with academic institutions, government agencies, and patient advocacy groups to co-develop value-based care models that enhance patient adherence and deliver measurable outcomes.

Conclusion and Strategic Imperatives

The consumer healthcare sector is poised for continued evolution as technological breakthroughs, regulatory shifts, and consumer empowerment reshape industry norms. Companies that demonstrate agility in manufacturing, foresight in digital adoption, and commitment to sustainability will secure competitive advantage. Strategic alignment across R&D, supply chain, marketing, and regulatory functions will drive seamless product-to-patient pathways, while robust collaboration with external stakeholders will accelerate innovation and market penetration. By leveraging data-driven insights and maintaining a customer-centric ethos, market players can navigate tariff-induced cost pressures, capitalize on regional growth pockets, and meet the diverse needs of health-conscious consumers. This conclusion underscores the imperative for integrated strategies and proactive adaptation in a dynamic global landscape.

Market Segmentation & Coverage

This research report categorizes the Consumer Healthcare Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Over-The-Counter (OTC) Drugs
  • Prescription Drugs
  • Liquid Dosage Form
    • Suspensions
    • Syrups
  • Semi-Solid Dosage Form
    • Gels
    • Ointments
  • Solid Dosage Form
    • Capsules
    • Powders
    • Tablets
  • Dermatology
  • Diabetes Care
  • Gastroenterology
  • Pain Management
  • Direct Sales
  • Online Stores
  • Retail Stores
    • Pharmacies
    • Supermarkets
  • Adult Population
    • Young Adults
  • Geriatric Population
  • Pediatric Population
  • Active Ingredients
    • Natural Compounds
  • Inactive Ingredients
    • Binders
    • Preservatives
  • Cardiovascular Diseases
  • Neurological Disorders
  • Respiratory Diseases
  • Blister Packs
  • Bottles
  • Tubes
  • Brand Savvy Consumers
  • Economical Buyers
  • Environmental Conscious Buyers
  • Autoimmune Disorders
  • Infectious Diseases
  • Oncology
    • Chemotherapy Agents
    • Immunotherapy
  • Curative Treatment
  • Symptomatic Treatment

This research report categorizes the Consumer Healthcare Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Consumer Healthcare Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories Inc.
  • Alembic Pharmaceuticals Ltd.
  • Alkem Laboratories Limited
  • AMCO Proteins
  • American Health Inc.
  • Amway Corporation by Alticor corporation
  • Axtria Inc.
  • BASF SE
  • Bayer AG
  • Bionova Lifesciences by Pragati Biocare Pvt. Ltd.
  • Boehringer Ingelheim International GmbH
  • Cipla, Inc.
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • Endo Pharmaceuticals PLC by DuPont de Nemours, Inc.
  • Gemini Pharmaceuticals Inc.
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • Henin Lukinz Pvt. Ltd.
  • Herbalife Ltd.
  • Hetero Drugs Ltd.
  • Himalaya Wellness Company
  • Iovate Health Sciences International Inc.
  • Ipsen S.A.
  • Johnson & Johnson Services, Inc.
  • Koninklijke DSM N.V.
  • Lonza Group Ltd.
  • Lupin Limited
  • Mankind Pharma
  • MusclePharm Corporation
  • Mylan Pharmaceuticals Pvt. Ltd. by Viatris
  • Nature's Bounty, Inc. by Nestlé S.A.
  • Novartis AG
  • Omega Protein Corporation
  • Pfizer Inc.
  • Piramal Group
  • Procter & Gamble Company
  • PureTek Corporation
  • QuestNutrition
  • Reckitt Benckiser Group PLC
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Ventus Pharmaceuticals Private Limited
  • Zoic Biotech Private Limited

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Consumer Healthcare Market, by Product Type
8.1. Introduction
8.2. Over-The-Counter (OTC) Drugs
8.3. Prescription Drugs
9. Consumer Healthcare Market, by Formulation
9.1. Introduction
9.2. Liquid Dosage Form
9.2.1. Suspensions
9.2.2. Syrups
9.3. Semi-Solid Dosage Form
9.3.1. Gels
9.3.2. Ointments
9.4. Solid Dosage Form
9.4.1. Capsules
9.4.2. Powders
9.4.3. Tablets
10. Consumer Healthcare Market, by Application
10.1. Introduction
10.2. Dermatology
10.3. Diabetes Care
10.4. Gastroenterology
10.5. Pain Management
11. Consumer Healthcare Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Online Stores
11.4. Retail Stores
11.4.1. Pharmacies
11.4.2. Supermarkets
12. Consumer Healthcare Market, by End-User
12.1. Introduction
12.2. Adult Population
12.2.1. Young Adults
12.3. Geriatric Population
12.4. Pediatric Population
13. Consumer Healthcare Market, by Ingredient
13.1. Introduction
13.2. Active Ingredients
13.2.1. Natural Compounds
13.3. Inactive Ingredients
13.3.1. Binders
13.3.2. Preservatives
14. Consumer Healthcare Market, by Disease Indication
14.1. Introduction
14.2. Cardiovascular Diseases
14.3. Neurological Disorders
14.4. Respiratory Diseases
15. Consumer Healthcare Market, by Packaging
15.1. Introduction
15.2. Blister Packs
15.3. Bottles
15.4. Tubes
16. Consumer Healthcare Market, by User Preference
16.1. Introduction
16.2. Brand Savvy Consumers
16.3. Economical Buyers
16.4. Environmental Conscious Buyers
17. Consumer Healthcare Market, by Therapeutic Area
17.1. Introduction
17.2. Autoimmune Disorders
17.3. Infectious Diseases
17.4. Oncology
17.4.1. Chemotherapy Agents
17.4.2. Immunotherapy
18. Consumer Healthcare Market, by Treatment Type
18.1. Introduction
18.2. Curative Treatment
18.3. Symptomatic Treatment
19. Americas Consumer Healthcare Market
19.1. Introduction
19.2. Argentina
19.3. Brazil
19.4. Canada
19.5. Mexico
19.6. United States
20. Asia-Pacific Consumer Healthcare Market
20.1. Introduction
20.2. Australia
20.3. China
20.4. India
20.5. Indonesia
20.6. Japan
20.7. Malaysia
20.8. Philippines
20.9. Singapore
20.10. South Korea
20.11. Taiwan
20.12. Thailand
20.13. Vietnam
21. Europe, Middle East & Africa Consumer Healthcare Market
21.1. Introduction
21.2. Denmark
21.3. Egypt
21.4. Finland
21.5. France
21.6. Germany
21.7. Israel
21.8. Italy
21.9. Netherlands
21.10. Nigeria
21.11. Norway
21.12. Poland
21.13. Qatar
21.14. Russia
21.15. Saudi Arabia
21.16. South Africa
21.17. Spain
21.18. Sweden
21.19. Switzerland
21.20. Turkey
21.21. United Arab Emirates
21.22. United Kingdom
22. Competitive Landscape
22.1. Market Share Analysis, 2024
22.2. FPNV Positioning Matrix, 2024
22.3. Competitive Analysis
22.3.1. Abbott Laboratories Inc.
22.3.2. Alembic Pharmaceuticals Ltd.
22.3.3. Alkem Laboratories Limited
22.3.4. AMCO Proteins
22.3.5. American Health Inc.
22.3.6. Amway Corporation by Alticor corporation
22.3.7. Axtria Inc.
22.3.8. BASF SE
22.3.9. Bayer AG
22.3.10. Bionova Lifesciences by Pragati Biocare Pvt. Ltd.
22.3.11. Boehringer Ingelheim International GmbH
22.3.12. Cipla, Inc.
22.3.13. Dr. Reddy's Laboratories
22.3.14. Eli Lilly and Company
22.3.15. Endo Pharmaceuticals PLC by DuPont de Nemours, Inc.
22.3.16. Gemini Pharmaceuticals Inc.
22.3.17. Glanbia PLC
22.3.18. GlaxoSmithKline PLC
22.3.19. Glenmark Pharmaceuticals Ltd.
22.3.20. Henin Lukinz Pvt. Ltd.
22.3.21. Herbalife Ltd.
22.3.22. Hetero Drugs Ltd.
22.3.23. Himalaya Wellness Company
22.3.24. Iovate Health Sciences International Inc.
22.3.25. Ipsen S.A.
22.3.26. Johnson & Johnson Services, Inc.
22.3.27. Koninklijke DSM N.V.
22.3.28. Lonza Group Ltd.
22.3.29. Lupin Limited
22.3.30. Mankind Pharma
22.3.31. MusclePharm Corporation
22.3.32. Mylan Pharmaceuticals Pvt. Ltd. by Viatris
22.3.33. Nature's Bounty, Inc. by Nestlé S.A.
22.3.34. Novartis AG
22.3.35. Omega Protein Corporation
22.3.36. Pfizer Inc.
22.3.37. Piramal Group
22.3.38. Procter & Gamble Company
22.3.39. PureTek Corporation
22.3.40. QuestNutrition
22.3.41. Reckitt Benckiser Group PLC
22.3.42. Sanofi S.A.
22.3.43. Sun Pharmaceutical Industries Limited
22.3.44. Takeda Pharmaceutical Company Limited
22.3.45. Teva Pharmaceutical Industries Ltd.
22.3.46. Ventus Pharmaceuticals Private Limited
22.3.47. Zoic Biotech Private Limited
23. ResearchAI
24. ResearchStatistics
25. ResearchContacts
26. ResearchArticles
27. Appendix
List of Figures
FIGURE 1. CONSUMER HEALTHCARE MARKET MULTI-CURRENCY
FIGURE 2. CONSUMER HEALTHCARE MARKET MULTI-LANGUAGE
FIGURE 3. CONSUMER HEALTHCARE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2024 VS 2030 (%)
FIGURE 22. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2024 VS 2030 (%)
FIGURE 24. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 26. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 28. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 32. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 36. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 37. CONSUMER HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 38. CONSUMER HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONSUMER HEALTHCARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY OVER-THE-COUNTER (OTC) DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SYRUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DIABETES CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY GERIATRIC POPULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PEDIATRIC POPULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY NATURAL COMPOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY BINDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY BRAND SAVVY CONSUMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY ECONOMICAL BUYERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY ENVIRONMENTAL CONSCIOUS BUYERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY CHEMOTHERAPY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY CURATIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SYMPTOMATIC TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 131. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 132. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 133. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 134. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 137. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 139. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 140. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 141. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 142. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 143. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 144. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 145. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 146. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 147. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 148. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 150. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 151. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 152. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 153. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 156. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 158. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 159. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 160. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 161. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 162. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 163. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 164. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 165. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 166. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 226. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 228. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 229. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 230. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 231. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 234. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 236. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 237. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 238. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 239. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 240. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 241. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 242. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 243. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 244. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 245. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 247. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 248. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 249. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 250. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 253. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 255. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 256. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 257. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 258. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 259. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 260. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 261. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 262. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 263. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 268. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 269. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 283. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 285. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 286. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 287. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 288. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 291. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 292. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 293. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 294. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 295. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 296. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 297. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 298. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 299. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 300. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 301. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 309. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 310. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 311. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 312. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 313. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 314. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 315. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 316. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 317. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 318. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 319. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 320. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 321. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 322. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 323. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY LIQUID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 324. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY SEMI-SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 325. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY SOLID DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY ADULT POPULATION, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY INGREDIENT, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY INACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY USER PREFERENCE, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY ONCOLOGY, 2018-203

Companies Mentioned

  • Abbott Laboratories Inc.
  • Alembic Pharmaceuticals Ltd.
  • Alkem Laboratories Limited
  • AMCO Proteins
  • American Health Inc.
  • Amway Corporation by Alticor corporation
  • Axtria Inc.
  • BASF SE
  • Bayer AG
  • Bionova Lifesciences by Pragati Biocare Pvt. Ltd.
  • Boehringer Ingelheim International GmbH
  • Cipla, Inc.
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • Endo Pharmaceuticals PLC by DuPont de Nemours, Inc.
  • Gemini Pharmaceuticals Inc.
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • Henin Lukinz Pvt. Ltd.
  • Herbalife Ltd.
  • Hetero Drugs Ltd.
  • Himalaya Wellness Company
  • Iovate Health Sciences International Inc.
  • Ipsen S.A.
  • Johnson & Johnson Services, Inc.
  • Koninklijke DSM N.V.
  • Lonza Group Ltd.
  • Lupin Limited
  • Mankind Pharma
  • MusclePharm Corporation
  • Mylan Pharmaceuticals Pvt. Ltd. by Viatris
  • Nature's Bounty, Inc. by Nestlé S.A.
  • Novartis AG
  • Omega Protein Corporation
  • Pfizer Inc.
  • Piramal Group
  • Procter & Gamble Company
  • PureTek Corporation
  • QuestNutrition
  • Reckitt Benckiser Group PLC
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Ventus Pharmaceuticals Private Limited
  • Zoic Biotech Private Limited

Methodology

Loading
LOADING...

Related Topics

Related Reports

Consumer Healthcare Market Report 2025 - Product Image

Consumer Healthcare Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Consumer Healthcare Market 2025-2029 - Product Image

Consumer Healthcare Market 2025-2029

  • Report
  • 198 Pages
  • Global
From
OTC Consumer Healthcare Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

OTC Consumer Healthcare Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 300 Pages
  • Global
From
Voice of the Consumer: Consumer Health 2024 - Product Image

Voice of the Consumer: Consumer Health 2024

  • Report
  • 25 Pages
  • Global
From
Where Consumers Shop for Consumer Health - Product Image

Where Consumers Shop for Consumer Health

  • Report
  • 36 Pages
  • Global
From

About the Consumer Healthcare Market

The Consumer Healthcare market is a segment of the Healthcare Services industry that focuses on providing healthcare products and services directly to consumers. This includes over-the-counter medications, vitamins, supplements, and other health-related products. It also includes services such as telemedicine, health coaching, and health education. Consumer Healthcare is a rapidly growing sector, driven by the increasing demand for convenient and affordable healthcare solutions. The Consumer Healthcare market is highly competitive, with a wide range of companies offering products and services. Examples of companies in this market include CVS Health, Walgreens, Rite Aid, GNC, and Wal-Mart. Other companies include Amazon, Teladoc, and Doctor on Demand. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.